# US 2004/0202671 A1 · Use of parasitic biological agents for prevention and control of autoimmune diseases

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2004/0202671 A1
- Document ID: US20040202671A1
- Status: Published application
- Kind: A1
- Application number: 10/779,249
- Filed: 2004-02-13
- Published: 2004-10-14
- Earliest claimed: 1997-12-31
- Assignees: University of Iowa Research Foundation
- Inventors: Joel V. Weinstock; David E. Elliott
- Web page: https://patentgrep.com/patent/US20040202671A1

## CPC

- A61K 35/62: Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
- A61P 1/00: Drugs for disorders of the alimentary tract or the digestive system
- A61P 1/04: for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A61P 3/10: for hyperglycaemia, e.g. antidiabetics
- A61P 17/00: Drugs for dermatological disorders
- A61P 19/02: for joint disorders, e.g. arthritis, arthrosis
- A61P 21/00: Drugs for disorders of the muscular or neuromuscular system
- A61P 25/00: Drugs for disorders of the nervous system
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P 37/00: Drugs for immunological or allergic disorders
- A61P 37/02: Immunomodulators
- A61P 37/06: Immunosuppressants, e.g. drugs for graft rejection
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- Y10S 530/855: Proteins from animals other than mammals or birds
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- Y10S: TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS

## Abstract

The invention relates to a method of treating an excessive immune response including an aberrant/enhanced Th1 response by administering a helminthic parasite preparation in an amount sufficient to reduce the excessive immune response in an individual. This invention is generally directed to autoimmune diseases which involve an excessive immune response or an aberrant/enhanced Th1 response. More specifically, the present invention is directed to the treatment of Crohn's disease and ulcerative colitis, both known as IBD. While the present invention discloses specific information about the treatment of IBD, the disclosure is in no way limiting. Additionally, rheumatoid arthritis, type 1 diabetes mellitus, lupus erythematosis, sarcoidosis and multiple sclerosis can be treated by the methods and compositions disclosed therein.

## Claims

### Claim 1

A pharmaceutical composition comprising an isolated and purified helminthic parasite preparation, wherein said preparation is prepared from helminths obtained from preparatory animals raised in a specific human pathogen-free environment, and a pharmaceutically acceptable carrier, and wherein said pharmaceutical composition is free of human pathogens.

### Claim 2 (depends on 1)

The composition of claim 1, wherein the helminthic parasite preparation is prepared from helminths selected from the group consisting of parasite, parasite extract, parasite eggs, parasite egg extract, parasite larvae, parasite larvae extract, parasite cercariae, and parasite cercariae extracts.

### Claim 3 (depends on 1)

The composition of claim 1, wherein the helminth parasite preparation is prepared from a parasite which is a nematode.

### Claim 4 (depends on 3)

The composition of claim 3, wherein the helminth parasite preparation is prepared from a parasite selected from the group consisting of Ascaris lumbricoides, Enterobius vermicularis, Trichuris trichiura, Ancylostoma duodenale, Necator americanus, Strongyloides stercoralis and Trichinella spiralis.

### Claim 5 (depends on 1)

The composition of claim 1, wherein the helminthic parasite preparation is prepared from a parasite which is a platyhelminth.

### Claim 6 (depends on 5)

The composition of claim 5, wherein the helminth parasite preparation is prepared from a parasite selected from the group consisting of trematodes and ceptodes.

### Claim 7 (depends on 6)

The composition of claim 6, wherein the helminthic parasite preparation is prepared from a parasite selected from the group consisting of Fasciolopsis species, Echinostoma species, Heterophyes species, Clonorchis sinensis, Opisthorchis viverrini, Opisthorchis felineus, Fasciola hepatica, Schistosoma species, Diphyllobothrium species, Taenia saginata, Taenia solium and Hymenolepsis nana.

### Claim 8 (depends on 1)

The composition of claim 1, wherein the helminthic parasite preparation is prepared from a parasite selected from the group consisting of filarial parasites and lung flukes.

### Claim 9 (depends on 1)

The composition of claim 1, wherein the helminthic parasite preparation is prepared from a parasite selected from the group consisting of Trichuris muris, Trichinelal spiralis, Nippostrongylus prasiliensis, Heligmonsomoides polygyrus, Hymenolepsis nanan, Angiostrongylus species, Trichuris suis, Ascaris suum, Trichuris vulpis, Toxocara species, Gnathostoma species, Ancylostoma species, Anisakis species and Pseudoterranova species.

### Claim 10 (depends on 1)

The composition of claim 1, wherein the helminthic parasite preparation is prepared from a parasite selected from Trichuris suis and Heligmonsomoides polygyrus.
